Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...
The Shanghai Hongqiao Railway Station is expected to handle the bulk of arrivals with 468,000 passengers, followed by ...
Chinese New Year or Lunar New Year, and there are many events planned in the capital so we are devoting a few of our five things to saying “Gung hei fat choi” – Congratulations and may you be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback